Should ethanol be scheduled as a drug of high risk to public health?
Six criteria described in the New Zealand Misuse of Drugs Act and used by the Expert Advisory Committee on Drugs (EACD) for determining the risk of a drug to public health were examined in relation to ethanol, using gamma-hydroxybutyric acid (GHB) as a comparator drug. GHB is an ideal candidate for use as a comparator because it is a sedative substance very similar to ethanol and has been previously investigated by the EACD using these six criteria. GHB was subsequently classified as a Class B1 drug under the Misuse of Drugs Act, that is, as a prohibited drug of high risk to public health. The dangerousness level of ethanol was found to be at least similar to that of GHB in this analysis. This highlights a major discrepancy in public policy.
Sellman
J D
JD
National Addiction Centre, University of Otago, Christchurch, New Zealand. doug.sellman@otago.ac.nz
Robinson
G M
GM
Beasley
R
R
D002492:Central Nervous System Depressants / Q000633:toxicity*; D000431:Ethanol / Q000633:toxicity*; D033161:Government Regulation; D006801:Humans; D007880:Legislation, Drug; D009520:New Zealand / Q000453:epidemiology; D011634:Public Health / Q000331:legislation & jurisprudence*; D018570:Risk Assessment; D012307:Risk Factors; D012978:Sodium Oxybate / Q000009:adverse effects / Q000592:standards / Q000633:toxicity; D019966:Substance-Related Disorders / Q000453:epidemiology
D002492:Central Nervous System Depressants; D000431:Ethanol; D012978:Sodium Oxybate